Wolff–Parkinson–White syndrome: Difference between revisions
Line 35: | Line 35: | ||
**Do NOT treat like paroxysmal SVT | **Do NOT treat like paroxysmal SVT | ||
***Contraindicated: CCBs, BBs, digoxin, adenosine | ***Contraindicated: CCBs, BBs, digoxin, adenosine | ||
** | **Cardioversion (synchronized) | ||
***Adult: 50-100 J | ***Adult: 50-100 J | ||
***Peds: 0.5- 2 J/kg | ***Peds: 0.5- 2 J/kg | ||
**Procainamide 100mg q10min until dysrhythmia terminated or max dose (1000mg) | |||
**Amiodarone | |||
Revision as of 07:16, 4 May 2011
Background
- Orthodromic (~95%)
- Accessory pathway used for retrograde reentry conduction
- QRS narrow (delta wave absent)
- May see ST depression, TWI
- Rate 150-250 bpm
- Accessory pathway used for retrograde reentry conduction
- Antidromic (~5%)
- Accessory pathway used for anterograde conduction
- QRS wide, delta wave present
- Accessory pathway used for anterograde conduction
- Atrial fibrillation seen in 10-30%
- Any pt w/ ventricular rate >300 should suspect preexcitation
Diagnosis
- Characteristic features not always seen on ECG
- Short PR interval - <0.12sec
- Due to loss of normal AV node conduction delay
- Delta wave / slurred upstroke
- Due to early activation of vent myocardium
- QRS duration > 0.10 sec
- Due to delta wave
Treatment
- Orthodromic
- Treat like paroxysmal SVT
- CCBs, BBs, procainamide, or adenosine
- Procainamide safe irrespective of type of pathway conduction
- Cardiovert (sync) if unstable
- Adult: 50-100 J
- Peds: 0.5- 2 J/kg
- Treat like paroxysmal SVT
- Antidromic
- Do NOT treat like paroxysmal SVT
- Contraindicated: CCBs, BBs, digoxin, adenosine
- Cardioversion (synchronized)
- Adult: 50-100 J
- Peds: 0.5- 2 J/kg
- Procainamide 100mg q10min until dysrhythmia terminated or max dose (1000mg)
- Amiodarone
- Do NOT treat like paroxysmal SVT
- Irregular tachycardia
- Treat like antidromic
Disposition
- Admission:
- Cardioverted, chest pain, CHF, or electrolyte imbalance
- Discharge
- If easily terminated d/c w/ outpt EP study